SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients
Main Authors: | Wang, Yi-Wei, Zhang, Shao-Dan, Xue, Wen-Ji, Zhu, Mei-Ling, Zheng, Lei-Zhen |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699293/ |
Similar Items
-
Medical Practice, Urban Politics and Patronage: The London ‘Commonalty’ of Physicians and Surgeons of the 1420s
*
by: Colson, Justin, et al.
Published: (2015) -
Cervical Radiculopathy: Incidence and Treatment of 1,420 Consecutive Cases
by: Kim, Han Jo, et al.
Published: (2016) -
SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
by: Shanglei Ning, et al.
Published: (2018-01-01) -
Primary gastric Hodgkin's lymphoma
by: Jung, Ji-Han, et al.
Published: (2012) -
Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
by: Chang, Sun Hee, et al.
Published: (2015)